This site was built with web standards. You are currently viewing the unformatted version of the website. Please update your browser in order to view the site.
Internet Explorer 5 or greater
Netscape 7
Mozilla
Opera 6 or greater
Recent advances in molecular biology have contributed significantly to our understanding of cancer genetics and tumor formation. As we continue to study normal and aberrant cell physiology, therapeutic agents targeted specifically at cancer cells continue to attract vast amounts of investigational attention. The following materials and Web links are provided to share information about HDAC and other emerging oncology targets with the goal of further improving patient treatment.
